STOCK TITAN

Arteris (AIP) COO Form 4 shows 1,420-share sale under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. Chief Operating Officer Moll Laurent R reported a small insider sale of common stock. On January 6, 2026, the executive sold 1,420 shares at a price of $16.23 per share. After this transaction, Moll Laurent R directly held 250,573 shares of Arteris common stock. The sale was made under a Rule 10b5-1 trading plan that the reporting person adopted on March 12, 2025, indicating it was pre-arranged rather than a discretionary market-timed trade.

Positive

  • None.

Negative

  • None.
Insider Moll Laurent R
Role Chief Operating Officer
Sold 1,420 shs ($23K)
Type Security Shares Price Value
Sale Common Stock 1,420 $16.23 $23K
Holdings After Transaction: Common Stock — 250,573 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moll Laurent R

(Last) (First) (Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CA 95008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/06/2026 S(1) 1,420 D $16.23 250,573 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R 01/08/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Arteris (AIP) report in this Form 4?

The filing reports that Chief Operating Officer Moll Laurent R sold 1,420 shares of Arteris, Inc. common stock on January 6, 2026.

At what price were the Arteris (AIP) shares sold and what was the total size?

The COO sold 1,420 shares of Arteris common stock at a price of $16.23 per share, as reported in the Form 4.

How many Arteris (AIP) shares does the insider hold after this transaction?

Following the reported sale, Moll Laurent R beneficially owned 250,573 shares of Arteris, Inc. common stock in direct ownership.

What is the role of Moll Laurent R at Arteris (AIP)?

Moll Laurent R is an officer of Arteris, Inc., serving as the company’s Chief Operating Officer, and is the reporting person on this Form 4.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 trading plan?

Yes. A footnote explains that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025.

Is this Arteris (AIP) Form 4 filing for direct or indirect ownership?

The Form 4 states that the 250,573 shares held after the transaction are owned directly by the reporting person.